Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 3/2021

01-08-2021 | Multiple Sclerosis | Original Article

Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease duration

Authors: Nuala McNicholas, Niall Tubridy, Michael Hutchinson, Chris McGuigan

Published in: Irish Journal of Medical Science (1971 -) | Issue 3/2021

Login to get access

Abstract

Background

Cognitive impairment (CI) is common in multiple sclerosis (MS), including newly diagnosed MS, where it is particularly underrecognised. Determining the presence of CI in the outpatient clinic often relies on patient-reported complaints, with limited time and resources in this setting. Prior studies have shown that self-reported cognition relates poorly to formal neuropsychological testing in the MS population and correlates more with factors such as anxiety, depression and fatigue.

Aims

In this study, we assess the prevalence of perceived cognitive dysfunction in newly diagnosed MS patients and compare results with an established MS cohort.

Results

Thirty-nine patients with newly diagnosed MS (12 months following diagnosis) and 24 patients with an established diagnosis (3 years) were included. Similar levels of perceived and objective CI were seen in both groups. There was a strong correlation of perceived cognitive dysfunction with anxiety, mood and fatigue. Perceived cognition did not correlate with objective CI, assessed using the Brief International Cognitive Assessment in MS (BICAMS), in either group.

Conclusions

Study findings add to the literature of perceived cognition in MS, in a newly diagnosed cohort. Findings are consistent with previous research using detailed neuropsychological assessments, confirming the sensitivity of BICAMS, applicable in a routine clinical setting.
Literature
1.
go back to reference Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139–1151CrossRef Chiaravalloti ND, DeLuca J (2008) Cognitive impairment in multiple sclerosis. Lancet Neurol 7(12):1139–1151CrossRef
2.
go back to reference Romero K, Shammi P, Feinstein A (2015) Neurologists’ accuracy in predicting cognitive impairment in multiple sclerosis. Mult Scler Relat Disord 4(4):291–295CrossRef Romero K, Shammi P, Feinstein A (2015) Neurologists’ accuracy in predicting cognitive impairment in multiple sclerosis. Mult Scler Relat Disord 4(4):291–295CrossRef
3.
go back to reference Julian L, Merluzzi N, Mohr D (2007) The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Mult Scler J 13(1):81–86CrossRef Julian L, Merluzzi N, Mohr D (2007) The relationship among depression, subjective cognitive impairment, and neuropsychological performance in multiple sclerosis. Mult Scler J 13(1):81–86CrossRef
4.
go back to reference Maor Y, Olmer L, Mozes B (2001) The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients--the role of depression. Mult Scler (Houndmills, Basingstoke, England) 7(2):131–135 Maor Y, Olmer L, Mozes B (2001) The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients--the role of depression. Mult Scler (Houndmills, Basingstoke, England) 7(2):131–135
5.
go back to reference Middleton LS, Denney DR, Lynch SG, Parmenter B (2006) The relationship between perceived and objective cognitive functioning in multiple sclerosis. Arch Clin Neuropsychol 21(5):487–494CrossRef Middleton LS, Denney DR, Lynch SG, Parmenter B (2006) The relationship between perceived and objective cognitive functioning in multiple sclerosis. Arch Clin Neuropsychol 21(5):487–494CrossRef
6.
go back to reference Benedict RH, Cox D, Thompson LL et al (2004) Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler J 10(6):675–678CrossRef Benedict RH, Cox D, Thompson LL et al (2004) Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler J 10(6):675–678CrossRef
7.
go back to reference Bruce JM, Arnett PA (2004) Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 26(2):200–214CrossRef Bruce JM, Arnett PA (2004) Self-reported everyday memory and depression in patients with multiple sclerosis. J Clin Exp Neuropsychol 26(2):200–214CrossRef
8.
go back to reference Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45(4):435–437CrossRef Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45(4):435–437CrossRef
9.
go back to reference Parmenter BA, Denney DR, Lynch SG (2003) The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler (Houndmills, Basingstoke, England) 9(2):111–118CrossRef Parmenter BA, Denney DR, Lynch SG (2003) The cognitive performance of patients with multiple sclerosis during periods of high and low fatigue. Mult Scler (Houndmills, Basingstoke, England) 9(2):111–118CrossRef
10.
go back to reference Klepstad P, Hilton P, Moen J et al (2002) Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16(6):513–519CrossRef Klepstad P, Hilton P, Moen J et al (2002) Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16(6):513–519CrossRef
11.
go back to reference Sawrie SM, Martin RC, Kuzniecky R et al (1999) Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology. 53(7):1511–1517CrossRef Sawrie SM, Martin RC, Kuzniecky R et al (1999) Subjective versus objective memory change after temporal lobe epilepsy surgery. Neurology. 53(7):1511–1517CrossRef
12.
go back to reference Royall DR, Mahurin R (1994) EXIT, QED, and DSM-IV: very early Alzheimer's disease. J Neuropsychiatry Clin Neurosci 6(1):62–65CrossRef Royall DR, Mahurin R (1994) EXIT, QED, and DSM-IV: very early Alzheimer's disease. J Neuropsychiatry Clin Neurosci 6(1):62–65CrossRef
13.
go back to reference Sullivan MEK, DeHousx E (1990) A survey of multiple sclerosis, part 1: perceived cognitive problems and compensatory strategy use. Can J Rehabil 4:99–105 Sullivan MEK, DeHousx E (1990) A survey of multiple sclerosis, part 1: perceived cognitive problems and compensatory strategy use. Can J Rehabil 4:99–105
14.
go back to reference Langdon D, Amato M, Boringa J et al (2012) Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler J 18(6):891–898CrossRef Langdon D, Amato M, Boringa J et al (2012) Recommendations for a brief international cognitive assessment for multiple sclerosis (BICAMS). Mult Scler J 18(6):891–898CrossRef
15.
go back to reference Honarmand K, Feinstein A (2009) Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scleros (Houndmills, Basingstoke, England) 15(12):1518–1524CrossRef Honarmand K, Feinstein A (2009) Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients. Mult Scleros (Houndmills, Basingstoke, England) 15(12):1518–1524CrossRef
16.
go back to reference Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123CrossRef Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121–1123CrossRef
17.
go back to reference O'Connell K, Langdon D, Tubridy N et al (2015) A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS). Mult Scler Relat Disord 4(6):521–525CrossRef O'Connell K, Langdon D, Tubridy N et al (2015) A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS). Mult Scler Relat Disord 4(6):521–525CrossRef
18.
go back to reference Randolph JJ, Randolph JS, Wishart HA (2017) Association between cognitive complaints and vulnerability to environmental distraction in multiple sclerosis. Arch Clin Neuropsychol 32(1):21–28CrossRef Randolph JJ, Randolph JS, Wishart HA (2017) Association between cognitive complaints and vulnerability to environmental distraction in multiple sclerosis. Arch Clin Neuropsychol 32(1):21–28CrossRef
Metadata
Title
Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease duration
Authors
Nuala McNicholas
Niall Tubridy
Michael Hutchinson
Chris McGuigan
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
Irish Journal of Medical Science (1971 -) / Issue 3/2021
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-020-02404-2

Other articles of this Issue 3/2021

Irish Journal of Medical Science (1971 -) 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.